Drug profile · INN
citalopram hydrobromide
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide (CITALOPRAM HYDROBROMIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — citalopram hydrobromide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
citalopram hydrobromide (CITALOPRAM HYDROBROMIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin transporter inhibitor
Primary target: Sodium-dependent serotonin transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is citalopram hydrobromide?
citalopram hydrobromide (CITALOPRAM HYDROBROMIDE) is a serotonin transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for citalopram hydrobromide?
CITALOPRAM HYDROBROMIDE is a marketed brand name for citalopram hydrobromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of citalopram hydrobromide?
citalopram hydrobromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.